Summary
In order to investigate the clinical efficacy of the triazole antifungal agent fluconazole (FCA) in the treatment of pulmonary mycosis, in the present study the concentrations of fluconazole in human pulmonary tissue, pericardial fluid and serum were determined at 1, 2, 12 and 13 h after intravenous administration of fluconazole 200 mg. The mean FCA concentrations in the serum were 4.04 mg/l (1 h), 3.82 mg/l (2 h), 2.35 mg/l (12 h) and 2.13 mg/l (13 h). The respective FCA levels in the pulmonary tissue were 4.64 mg/kg, 4.54 mg/kg; 3.50 mg/kg and 3.40 mg/kg and the concentrations in the pericardial fluid were 3.86 mg/l, 3.57 mg/l, 2.35 mg/l and 2.13 mg/l. The FCA concentrations in the pulmonary tissue that were statistically significant higher than the serum concentrations were found at 2 h, 12 h and 13 h after intravenous administration (p<0.05).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Marriot, M. S., Richardson, K. The discovery and mode of action of fluconazole. In:Fromtling, R. A. (ed.): Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous Science Publishers SA, Barcelona 1987, pp. 81–92.
Rex, J. H., Benett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., Levenstein, M. J., Webb, C. D., forthe Candidemia Study Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group A randomized trial comparing fluconazole with amphotericin B for the treatment ofcandidemia in patients without neutropenia. N. Engl. J. Med. 331 (1994) 1325–1330.
Saag, M. S., Powderly, W. G., Cloud, G. A., Robinson, P., Grieco, H. M., Sharkey, P. K., Thompson, S. E., Sugar, A. M., Tuazon, C. U., Fisher, J. F., Hyslop, N., Jacobsen, J. M., Hafner, R., Dismukes, W. E., NIAID Mycoses Study Group, AIDS Clinical Trials Group Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med. 326 (1992) 83–89.
Bozzette, S. A., Larsen, R. A., Chiu, J., Leal, M. A., Jacobsen, J., Rothmann, P., Robinson, P., Gilbert, G., McCutchan, J. A., Tilles, J., Leedom, M., Richman, D. D., andthe Californian Collaborative Treatment Group A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324 (1991) 580–584.
Catanzaro, A., Galgiani, J. N., Levine, B. E., Sharkey-Mathis, P. K., Fierer, J., Stevens, D. A., Chapman, S. W., Cloud, G., andthe NIAID Mycoses Study Group Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminatedcoccidioidomycosis. Am. J. Med. 98 (1995) 249–256.
Lyman, C. A., Sugar, A. M., Diamond, R. D. Comparative activities of UK-49,858 and amphotericin B againstBlastomyces dermatitidis infections in mice. Antimicrob. Agents Chemother. 29 (1986) 161–162.
Brammer, K. W., Tarbit, M. H. A review of the pharmacokinetics of fluconazole (UK-49,858) in laboratory animals and man. In:Fromtling, R. A. (ed): Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous Science Publishers, Barcelona 1987, pp. 141–149.
Wood, P. R., Tarbit, M. H. Gaschromatographic method for the determination of fluconazole, a novel antifungal agent in human plasma and urine. J. Chromatogr. 383 (1986) 179–186.
Ebden, P., Neill, P., Farrow, P. R. Sputum levels of fluconazole in humans. Antimicrob. Agents Chemother. 33 (1989) 963–964.
Ferrante, L., Bompadre, S., Cingolani, M. L., Leone, L., Ripa, S. Pharmacokinetics of fluconazole after iv administration. Pharmacol. Res. 25 (1992) 192–193.
Walsh, T. J., Foulds, G., Pizzo, P. A. Pharmacokinetics and tissue penetration of fluconazole in rabbits. Antimicrob. Agents Chemother. 33 (1989) 467–469.
Brammer, K. W., Farrow, P. R., Faulkner, J. K. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12 (1990) 318–326.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rieder-Nelissen, C.M., Hasse, J., Yeates, R.A. et al. Fluconazole concentrations in pulmonary tissue and pericardial fluid. Infection 25, 192–194 (1997). https://doi.org/10.1007/BF02113615
Issue Date:
DOI: https://doi.org/10.1007/BF02113615